Author:
Mahmood Syed S.,Fradley Michael G.,Cohen Justine V.,Nohria Anju,Reynolds Kerry L.,Heinzerling Lucie M.,Sullivan Ryan J.,Damrongwatanasuk Rongras,Chen Carol L.,Gupta Dipti,Kirchberger Michael C.,Awadalla Magid,Hassan Malek Z.O.,Moslehi Javid J.,Shah Sachin P.,Ganatra Sarju,Thavendiranathan Paaladinesh,Lawrence Donald P.,Groarke John D.,Neilan Tomas G.
Subject
Cardiology and Cardiovascular Medicine
Reference33 articles.
1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010
2. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011
3. Approved Drugs - Nivolumab (Dec 22, 2014). Silver Spring, MD: U.S. Food and Drug Administration, 2014.
4. Approved Drugs - Pembrolizumab (Sep 4, 2014). Silver Spring, MD: U.S. Food and Drug Administration, 2014.
5. Fulminant myocarditis with combination immune checkpoint blockade;Johnson;N Engl J Med,2016
Cited by
1035 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献